Food Study of Pioglitazone HCl Tablets 45 mg to Actos® Tablets 45 mg
Status:
Completed
Trial end date:
2003-03-01
Target enrollment:
Participant gender:
Summary
The objective of this study was to investigate the bioequivalence of Mylan pioglitazone HCl
45 mg tablets to Takeda Actos® 45 mg tablets following a single, oral 45 mg (1 x 45 mg) dose
administration under fed conditions.